COVID-19 and kidney transplantation: the impact of remdesivir on renal function and outcome - a retrospective cohort study

Beigel, 2020, ACTT-1 Study Group Members. Remdesivir for the Treatment of Covid-19 - Final Report, N Engl J Med, 383, 1813, 10.1056/NEJMoa2007764 Buxeda, 2021, Use and Safety of Remdesivir in Kidney Transplant Recipients With COVID-19, Kidney Int Rep, 6, 2305, 10.1016/j.ekir.2021.06.023 Chen, 2021, Incidence of Mortality, Acute Kidney Injury and Graft Loss in Adult Kidney Transplant Recipients with Coronavirus Disease 2019: Systematic Review and Meta-Analysis, J Clin Med, 10, 5162, 10.3390/jcm10215162 Deb, 2021, ADME and Pharmacokinetic Properties of Remdesivir: Its Drug Interaction Potential, Pharmaceuticals (Basel), 14, 655, 10.3390/ph14070655 Elec, 2021, COVID-19 after kidney transplantation: Early outcomes and renal function following antiviral treatment, Int J Infect Dis, 104, 426, 10.1016/j.ijid.2021.01.023 Elec, 2021, Comparing the First and Second Wave of COVID-19 in Kidney Transplant Recipients: An East-European Perspective, Eur Surg Res, 298 Elens, 2020, Pharmacologic Treatment of Transplant Recipients Infected With SARS-CoV-2: Considerations Regarding Therapeutic Drug Monitoring and Drug-Drug Interactions, Ther Drug Monit, 42, 360, 10.1097/FTD.0000000000000761 2020 Goldman, 2020, GS-US-540-5773 Investigators. Remdesivir for 5 or 10 Days in Patients with Severe Covid-19, N Engl J Med, 383, 1827, 10.1056/NEJMoa2015301 Harvey, 2014, Cancer, inflammation, and therapy: effects on cytochrome p450-mediated drug metabolism and implications for novel immunotherapeutic agents, Clin Pharmacol Ther, 96, 449, 10.1038/clpt.2014.143 Heldman, 2021, Changing Trends in Mortality Among Solid Organ Transplant Recipients Hospitalized for Covid-19 During the Course of the Pandemic, Am J Transplant Jager, 2020, Results from the ERA-EDTA Registry indicate a high mortality due to COVID-19 in dialysis patients and kidney transplant recipients across Europe, Kidney Int, 98, 1540, 10.1016/j.kint.2020.09.006 Jayant, 2021, The Impact of COVID-19 on Kidney Transplant Recipients in Pre-Vaccination and Delta Strain Era: A Systematic Review and Meta-Analysis, J Clin Med, 10, 4533, 10.3390/jcm10194533 Lo, 2017, GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo-, and Paramyxoviruses, Sci Rep., 7, 43395, 10.1038/srep43395 Luke, 2010, Review of the basic and clinical pharmacology of sulfobutylether-beta-cyclodextrin (SBECD), J Pharm Sci, 99, 3291, 10.1002/jps.22109 Maggiore, 2020, How should I manage immunosuppression in a kidney transplant patient with COVID-19? An ERA-EDTA DESCARTES expert opinion, Nephrol Dial Transplant, 35, 899, 10.1093/ndt/gfaa130 Meshram, 2021, Feasibility and safety of remdesivir in SARS-CoV2 infected renal transplant recipients: A retrospective cohort from a developing nation, Transpl Infect Dis, 23, e13629, 10.1111/tid.13629 Olender, 2021, Remdesivir for Severe Coronavirus Disease 2019 (COVID-19) Versus a Cohort Receiving Standard of Care, Clin Infect Dis, 73, e4166, 10.1093/cid/ciaa1041 Oltean, 2020, Covid-19 in kidney transplant recipients: a systematic review of the case series available three months into the pandemic, Infect Dis (Lond), 52, 830, 10.1080/23744235.2020.1792977 Oltean, 2012, Charlson's weighted index of comorbidities is useful in assessing the risk of death in septic patients, J Crit Care, 27, 370, 10.1016/j.jcrc.2011.08.021 Qin, 2021, Risk of Breakthrough SARS-CoV-2 Infections in Adult Transplant Recipients, Transplantation, 105, e265, 10.1097/TP.0000000000003907 Spinner, 2020, GS-US-540-5774 Investigators. Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19: A Randomized Clinical Trial, JAMA, 324, 1048, 10.1001/jama.2020.16349 Villanego, 2021, Spanish Society of Nephrology COVID-19 Group. Predictors of severe COVID-19 in kidney transplant recipients in the different epidemic waves: Analysis of the Spanish Registry, Am J Transplant, 21, 2573, 10.1111/ajt.16579 von Elm, 2007, The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies, Lancet, 370, 1453, 10.1016/S0140-6736(07)61602-X National Institutes of Health. COVID-19 Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. Available at https://www.covid19treatmentguidelines.nih.gov/overview/clinical-spectrum. Accessed Nov 2021.